Acceleron Pharma
(XLRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,053 | -118,871 | -84,136 | -55,156 | -26,219 |
| Depreciation Amortization | 933 | 3,747 | 2,868 | 1,866 | 904 |
| Accounts receivable | 4,259 | -3,470 | 312 | -99 | 338 |
| Accounts payable and accrued liabilities | 3,466 | -673 | 80 | 183 | 591 |
| Other Working Capital | 2,861 | -4,560 | -3,556 | -4,756 | -3,900 |
| Other Operating Activity | 226 | 29,121 | 18,754 | 12,380 | 4,855 |
| Operating Cash Flow | $-26,308 | $-94,706 | $-65,678 | $-45,582 | $-23,431 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 64,133 | 199,087 | 138,631 | 85,547 | 24,530 |
| PPE Investments | -587 | -2,590 | -1,901 | -1,373 | -504 |
| Purchase Of Investment | -216,116 | -73,570 | -73,570 | -66,113 | -35,947 |
| Investing Cash Flow | $-152,570 | $122,927 | $63,160 | $18,061 | $-11,921 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -139 | -78 | -78 | -78 |
| Common Stock Issued | 248,155 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 1,161 | 16,285 | 15,338 | 7,041 | 5,016 |
| Financing Cash Flow | $249,316 | $16,146 | $15,260 | $6,963 | $4,938 |
| Beginning Cash Position | 145,649 | 101,282 | 101,282 | 101,282 | 101,282 |
| End Cash Position | 216,087 | 145,649 | 114,024 | 80,724 | 70,868 |
| Net Cash Flow | $70,438 | $44,367 | $12,742 | $-20,558 | $-30,414 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,308 | -94,706 | -65,678 | -45,582 | -23,431 |
| Capital Expenditure | -587 | -2,590 | -1,901 | -1,373 | -504 |
| Free Cash Flow | -26,895 | -97,296 | -67,579 | -46,955 | -23,935 |